However, the pAKT and pERK levels in cells harboring HCC-derived EGFR mutants treated with EGF were much higher than their baseline without EGF, indicating that these HCC-derived EGFR mutants still response to EGF treatment and remain primarily EGF-dependent. The gene discussed is EGFR; the disease is hepatocellular carcinoma.